The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Opposite Regulation of Myc and p21 Transcription by STAT3 Proteins
Barré, B., Avril, S., & Coqueret, O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210422200 · Cited by 110
RetractedHsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Self-citationLynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
Mendelsohn, J., & Baselga, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.504 · Cited by 1,255
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Self-citationEnhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase
Ni, C.-Y., Murphy, M. P., Golde, T. E., & Carpenter, G. (2001) · Science · doi:10.1126/science.1065412 · Cited by 856
A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science · doi:10.1126/science.8066447 · Cited by 806
Lin, S.-Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., Pestell, R. G., & Hung, M.-C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060025397 · Cited by 783
Self-citationRoles of nitric oxide in tumor growth.
Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., & Moncada, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4392 · Cited by 780
A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles.
Cohen, S., Ushiro, H., Stoscheck, C., & Chinkers, M. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68224-4 · Cited by 776
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643
Binding of SH2 Domains of Phospholipase Cγ1, GAP, and Src to Activated Growth Factor Receptors
Anderson, D., Koch, C. A., Grey, L., Ellis, C., Moran, M. F., & Pawson, T. (1990) · Science · doi:10.1126/science.2173144 · Cited by 594
Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., & Hirano, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00734.x · Cited by 565
Wei, D., Le, X., Zheng, L., Wang, L., Frey, J. A., Gao, A. C., Peng, Z., Huang, S., Xiong, H. Q., Abbruzzese, J. L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206122 · Cited by 558
Wegenka, U. M., Buschmann, J., Lütticken, C., Heinrich, P. C., & Horn, F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.276 · Cited by 552
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Synergistic Roles for Pim-1 and c-Myc in STAT3-Mediated Cell Cycle Progression and Antiapoptosis
Shirogane, T., Fukada, T., Muller, J. M. M., Shima, D. T., Hibi, M., & Hirano, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80145-4 · Cited by 426
Hata, A., Seoane, J., Lagna, G., Montalvo, E., Hemmati-Brivanlou, A., & Massagué, J. (2000) · Cell · doi:10.1016/s0092-8674(00)81561-5 · Cited by 420
Masuda, M., Suzui, M., Yasumatu, R., Nakashima, T., Kuratomi, Y., Azuma, K., Tomita, K., Komiyama, S., & Weinstein, I. B. (2002) · PubMed · Cited by 376
Hu, P., Margolis, B., Skolnik, E. Y., Lammers, R., Ullrich, A., & Schlessinger, J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.981 · Cited by 321
Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB
Ganster, R. W., Taylor, B. S., Shao, L., & Geller, D. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151239498 · Cited by 321
The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumors
Ritter, C. A., & Arteaga, C. L. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50027 · Cited by 311
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
Wang, S.-C., Lien, H.-C., Xia, W., Chen, I.-F., Lo, H.-W., Wang, Z., Ali-Seyed, M., Lee, D.-F., Bartholomeusz, G., Ou-Yang, F., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.07.012 · Cited by 305
Self-citationXia, W., Lau, Y. K. J., Zhang, H. Z., Xiao, F. Y., Johnston, D. A., Liu, A. R., Li, L., Katz, R. L., & Hung, M. (1999) · PubMed · Cited by 295
Self-citationNovel Prognostic Value of Nuclear Epidermal Growth Factor Receptor in Breast Cancer
Lo, H.-W., Xia, W., Wei, Y., Ali-Seyed, M., Huang, S.-F., & Hung, M.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.338.65.1 · Cited by 290
Self-citationSinibaldi, D., Wharton, W., Turkson, J., Bowman, T., Pledger, W. J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203947 · Cited by 290
(2003) · PubMed · Cited by 272
Williams, C. C., Allison, J. G., Vidal, G. A., Burow, M. E., Beckman, B. S., Marrero, L., & Jones, F. E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403155 · Cited by 263
Targeting HER1/EGFR: A molecular approach to cancer therapy
Arteaga, C. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00185-4 · Cited by 251
Karni, R., Jove, R., & Levitzki, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202835 · Cited by 242
Rao, C. V., Cooma, I., Simi, B., Manning, P. T., Connor, J. R., & Reddy, B. S. (2002) · PubMed · Cited by 232
Importin β–Mediated Nuclear Import of Fibroblast Growth Factor Receptor
Reilly, J. F., & Maher, P. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1307 · Cited by 231
Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2.
Maher, P. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.2.529 · Cited by 224
Offterdinger, M., Schöfer, C., Weipoltshammer, K., & Grunt, T. W. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109033 · Cited by 208
In vitro activation of Stat3 by epidermal growth factor receptor kinase
Park, O. K., Schaefer, T. S., & Nathans, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13704 · Cited by 201
Role of nitric oxide in tumor progression: Lessons from experimental tumors
Lala, P. K., & Orucevic, A. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005960822365 · Cited by 198
Vakkala, M. A., Kahlos, K., Lakari, E., Pääkkö, P. K., Kinnula, V. L., & Soini, Y. (2000) · PubMed · Cited by 196
Ekmekçioglu, S., Ellerhorst, J. A., Smid, C. M., Prieto, V. G., Munsell, M. F., Buzaid, A. C., & Grimm, E. A. (2000) · PubMed · Cited by 192
Cohen, S., Fava, R. A., & Sawyer, S. T. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.20.6237 · Cited by 183
Jadeski, L. C., & Lala, P. K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65240-6 · Cited by 174
The identification of E2F1-specific target genes
Wells, J. M., Graveel, C. R., Bartley, S. M., Madore, S. J., & Farnham, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062047499 · Cited by 165
Inducible Nitric Oxide Synthase Expression in Human Colorectal Cancer
Cianchi, F., Cortesini, C., Fantappiè, O., Messerini, L., Schiavone, N., Vannacci, A., Nistri, S., Sardi, I., Baroni, G., Marzocca, C., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63876-x · Cited by 161
Maida, Y., Kyo, S., Kanaya, T., Wang, Z., Yatabe, N., Tanaka, M., Nakamura, M., Ohmichi, M., Gotoh, N., Murakami, S., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205509 · Cited by 161
Cytoplasmic transport of Stat3 by receptor‐mediated endocytosis
Bild, A. H., Turkson, J., & Jove, R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf351 · Cited by 160
Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling?
Jans, D. A., & Hassan, G. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199805)20:5<400::aid-bies7>3.0.co;2-r · Cited by 159
Signalling shortcuts: cell-surface receptors in the nucleus?
Wells, A. H., & Marti, U. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm905 · Cited by 150
Nuclear translocation of the insulin receptor. A possible mediator of insulin's long term effects.
Podlecki, D. A., Smith, R. M., Kao, M., Tsai, P., Huecksteadt, T. P., Brandenburg, D., Lasher, R. S., Jarett, L., & Olefsky, J. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61511-x · Cited by 138
Shao, H., Cheng, H. Y., Cook, R. G., & Tweardy, D. J. (2003) · PubMed · Cited by 136
Cyclooxygenase-2 Activation Mediates the Proangiogenic Effect of Nitric Oxide in Colorectal Cancer
Cianchi, F., Cortesini, C., Fantappiè, O., Messerini, L., Sardi, I., Lasagna, N., Perna, F., Fabbroni, V., Felice, A. D., Perigli, G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0192 · Cited by 136
Xie, Y., & Hung, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2368 · Cited by 134
Self-citationLocalization of epidermal growth factor receptor in hepatocyte nuclei
Marti, U., Burwen, S. J., Wells, A. H., Barker, M. E., Huling, S. L., Feren, A. M., & Jones, A. L. (1991) · Hepatology · doi:10.1002/hep.1840130104 · Cited by 129
Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers
Salzman, A. L., Denenberg, A. G., Ueta, I., O'Connor, M., Linn, S. C., & Szabó, C. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.270.4.g565 · Cited by 122
Fernandes, A. M., Hamburger, A. W., & Gerwin, B. I. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<564::aid-ijc20>3.0.co;2-q · Cited by 119
Feng, X., Guo, Z., Nourbakhsh, M., Häuser, H., Ganster, R. W., Shao, L., & Geller, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212306199 · Cited by 111
Khoury, J. D., Medeiros, L. J., Rassidakis, G. Z., Yared, M. A., Tsioli, P., Leventaki, V., Schmitt-Graeff, A. H., Herling, M., Amin, H. M., & Lai, R. L. (2003) · PubMed · Cited by 110
Hsiao, J. R., Jin, Y., Tsai, S., Shiau, A.-L., Wu, C., & Su, W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601003 · Cited by 98
Independent and Cooperative Activation of Chromosomal c-fos Promoter by STAT3
Yang, E., Lerner, L. R., Besser, D., & Darnell, J. E., Jr. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213073200 · Cited by 93
Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839
Albanell, J., Rojo, F., & Baselga, J. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90283-0 · Cited by 88
Violot, S., Hong, S. S., Rakotobe, D., Petit, C., Gay, B., Moreau, K., Billaud, G., Priet, S., Sire, J., Schwartz, O., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12507-12522.2003 · Cited by 87
In or out? The dynamics of Smad nucleocytoplasmic shuttling
Reguly, T., & Wrana, J. L. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00075-8 · Cited by 85
Larkin, J., Johnson, H. M., & Subramaniam, P. S. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050044769 · Cited by 76
Subramaniam, P. S., & Johnson, H. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1959 · Cited by 75
Fantappiè, O., Masini, E., Sardi, I., Raimondi, L., Bani, D., Solazzo, M., Vannacci, A., & Mazzanti, R. (2002) · Hepatology · doi:10.1053/jhep.2002.32469 · Cited by 71
Nuclear accumulation of interferon gamma.
Bader, T., & Weitzerbin, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11831 · Cited by 71
EGF Receptor Deletions Define a Region Specifically Mediating Stat Transcription Factor Activation
Coffer, P. J., & Kruijer, W. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1629 · Cited by 67
Dowlati, A., Nethery, D. E., & Kern, J. A. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.459.3.4 · Cited by 67
Liu, B., & Neufeld, A. H. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00010-x · Cited by 66
A decade of tyrosine kinases: from gene discovery to therapeutics
Craven, R. J., Lightfoot, H. M., & Cance, W. G. (2003) · Surgical Oncology · doi:10.1016/s0960-7404(03)00004-5 · Cited by 60
Jans, D. A., Briggs, L. J., Gustin, S. E., Jans, P., Ford, S. C., & Young, I. G. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00622-4 · Cited by 51
Localization of neuregulin isoforms and erbB receptors in myelinating glial cells
Raabe, T. D., Deadwyler, G., Varga, J. W., & DeVries, G. H. (2003) · Glia · doi:10.1002/glia.10311 · Cited by 47
Subramaniam, P. S., Green, M. M., Larkin, J., Torres, B. A., & Johnson, H. M. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001753289569 · Cited by 47
From PTK-STAT signaling to caspase expression and apoptosis induction
Fu, X.-Y. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400613 · Cited by 41
Selective Activation of Ceruloplasmin Promoter in Ovarian Tumors
Lee, C. M., Lo, H., Shao, R., Wang, S., Xia, W., Gershenson, D. M., & Hung, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2551 · Cited by 35
Self-citationGrasl‐Kraupp, B., Schausberger, E., Hufnagl, K., Gerner, C., Löw‐Baselli, A., Rossmanith, W., Parzefall, W., & Schulte‐Hermann, R. (2002) · Hepatology · doi:10.1053/jhep.2002.33203 · Cited by 32
Marti, U., & Hug, M. (1995) · Journal of Hepatology · doi:10.1016/s0168-8278(95)80011-5 · Cited by 28
Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase.
Rao, V. N., & Reddy, E. S. P. (1993) · PubMed · Cited by 27
Differential expression of nitric oxide synthases in EGF-responsive mouse neural precursor cells
Wang, T., FitzGerald, T. J., & Haregewoin, A. (1999) · Cell and Tissue Research · doi:10.1007/s004410051309 · Cited by 24
Receptors of Glutamate and Neurotrophin in Vestibular Neuronal Functions
Chan, Y., Chen, L. W., Lai, C. H., Shum, D. K., Yung, K. K. L., & Zhang, F. X. (2003) · Journal of Biomedical Science · doi:10.1007/bf02256307 · Cited by 11
Cited by
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
The molecular biology of head and neck cancer
Leemans, C. R., Braakhuis, B. J. M., & Brakenhoff, R. H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2982 · Cited by 2,524
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Wee, P., & Wang, Z. (2017) · Cancers · doi:10.3390/cancers9050052 · Cited by 2,027
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
Metadata
- Authors
- Lo, H.-W., Hsu, S.-C., Ali-Seyed, M., Gunduz, M., Xia, W., Wei, Y., Bartholomeusz, G., Shih, J.-Y., & Hung, M.-C.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 7
- Issue
- 6
- Pages
- 575-589
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2087032518
- Cited by
- 544
- References
- 86
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.